Below are the most recent publications written about "Bile Duct Neoplasms" by people in Profiles.
-
Mou H, Ozata DM, Smith JL, Sheel A, Kwan SY, Hough S, Kucukural A, Kennedy Z, Cao Y, Xue W. CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling. Genome Med. 2019 04 16; 11(1):21.
-
Bledsoe JR, Shinagare SA, Deshpande V. Difficult Diagnostic Problems in Pancreatobiliary Neoplasia. Arch Pathol Lab Med. 2015 Jul; 139(7):848-57.
-
Loh KP, Nautsch D, Desilets D, Mehendiratta V. A rare cause of dilated bile duct incidentally detected on imaging. BMJ Case Rep. 2014 May 23; 2014.
-
Gao Y, Yang M, Jiang Z, Woda BA, Mercurio AM, Qin J, Huang X, Zhang F. IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma. Hum Pathol. 2014 Jun; 45(6):1184-91.
-
Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C, Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology. 2013 Apr; 144(4):829-40.
-
Loew BJ, Howell DA, Sanders MK, Desilets DJ, Kortan PP, May GR, Shah RJ, Chen YK, Parsons WG, Hawes RH, Cotton PB, Slivka AA, Ahmad J, Lehman GA, Sherman S, Neuhaus H, Schumacher BM. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc. 2009 Sep; 70(3):445-53.
-
Wassef W, Syed I. Designer stents: are we there yet? Gastrointest Endosc. 2007 Oct; 66(4):804-8.
-
Lee MG, Lee HJ, Kim MH, Kang EM, Kim YH, Lee SG, Kim PN, Ha HK, Auh YH. Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography. Radiology. 1997 Mar; 202(3):663-9.
-
Mitty R, Cave DR. Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Gastrointest Endosc. 1995 Sep; 42(3):281-2.